| Literature DB >> 22022309 |
Patricia V Agostino1, Diego A Golombek, Warren H Meck.
Abstract
Neural timing mechanisms range from the millisecond to diurnal, and possibly annual, frequencies. Two of the main processes under study are the interval timer (seconds-to-minute range) and the circadian clock. The molecular basis of these two mechanisms is the subject of intense research, as well as their possible relationship. This article summarizes data from studies investigating a possible interaction between interval and circadian timing and reviews the molecular basis of both mechanisms, including the discussion of the contribution from studies of genetically modified animal models. While there is currently no common neurochemical substrate for timing mechanisms in the brain, circadian modulation of interval timing suggests an interaction of different frequencies in cerebral temporal processes.Entities:
Keywords: circadian system; cortico-striatal circuits; dopamine; glutamate; interval timing; serotonin; suprachiasmatic nuclei
Year: 2011 PMID: 22022309 PMCID: PMC3196210 DOI: 10.3389/fnint.2011.00064
Source DB: PubMed Journal: Front Integr Neurosci ISSN: 1662-5145
Glossary of timing terms.
| Interval timing | Typically defined at the discrimination of durations in the seconds-to-minutes range, but can be extended to both shorter (e.g., milliseconds) and longer (e.g., hours) ranges. Interval timing is less precise than circadian timing, but has an advantage in increased flexibility in that it can run, stop/pause, and reset on command (Gibbon et al., |
| Scalar property/Weber’s law | The scalar property is one of the hallmark signatures of interval timing. It describes the linear relationship between target durations and the standard deviation (SD) of duration judgments, indicating that variability in timing behavior grows proportional to the mean of the interval being estimated. In this sense, duration discrimination is relative rather than absolute, i.e., time perception is like a rubber band that can be stretched in order to produce time scale invariance across different durations (Gibbon et al., |
| Circadian rhythms | The circadian clock is a self-sustained biological oscillator with a period near to 24 h. In mammals, the circadian pacemaker is located in the suprachiasmatic nuclei (SCN) of the hypothalamus, and the principal signal that adjusts its activity is the light–dark cycle (Morin and Allen, |
| Clock genes | The so-called |
Figure 1(A) Main components of the circadian timing system. Circadian rhythms consists of three main components: (i) an input pathway integrating exogenous signals to synchronize circadian phase and period, (ii) a central oscillator that generates the endogenous circadian signal, and (iii) an output pathway driving circadian periodicity and coupling of biological processes. (B) Molecular mechanisms of circadian timing. The molecular mechanisms of circadian rhythms can be illustrated by the transcription of the Period (Per1and Per2) and Cryptochrome (Cry1, Cry2) genes that are activated by heteromeric complexes containing CLOCK and BMAL1 proteins that act through the E-box regulatory sequences of their target genes. The newly synthesized PER and CRY proteins are translocated into the nucleus, where they inhibit BMAL1–CLOCK activity, and therefore, their own transcription. Clock and Bmal1 both contain basic helix–loop–helix (bHLH) motifs for DNA binding at their N-terminus and Per–Arnt–Sim (PAS) domains. The controlled degradation of PER and CRY proteins by the ubiquitin pathway decreases their protein levels and results in an oscillation of their mRNA and protein levels. During this negative transcriptional feedback loop many of the clock proteins become posttranslationally modified by phosphorylation and ubiquitination (Reppert and Weaver, 2002). This core oscillation is augmented and stabilized by a secondary loop involving two orphan nuclear receptor proteins, REV-ERBα and RORA. Both are activated in phase with the Per and Cry genes by CLOCK and BMAL1, but in turn they affect Bmal1 expression (Preitner et al., 2002). While RORA has a positive role, REV-ERBα is a suppressor of Bmal1, and they coordinate action through RORE regulatory sequences. A positive feedback loop is built by the stimulated transcription of BMAL1 by PER2. Protein phosphorylation events are essential contributors to these feedback loops. Two members of the casein kinase I family (CKIε and CKIδ) phosphorylate PER proteins in order to (i) target them for ubiquitin-mediated proteasomal degradation, and (ii) modulate their nuclear import. A mutation of CKIε shortens rhythm in hamsters (Lowrey et al., 2000) and a mutation of CKIδ shortens rhythm in humans (Xu et al., 2005). The result of these complex regulatory pathways is that the mRNA and protein levels of most circadian genes – except Clock and CKIε – oscillate with a 24-h period. Importantly, the CLOCK–BMAL1 heterodimer regulates the transcription of many clock-controlled genes (CCGs), which in turn influence a wide array of physiological functions external to the oscillatory mechanism. This mediates the output function of the clock, thereby controlling food intake, hormonal synthesis and release, body temperature, metabolism, and many other functions.
Phenotypes of different mutant mice.
| Genotype | Physiological and behavioral alterations | Circadian phenotype | FAA | Interval timing |
|---|---|---|---|---|
| Clock−/− mice | Metabolic and sleep patterns; drugs sensitization | Longer period/arrhythmic (Vitaterna et al., | Normal (Pitts et al., | Normal (Cordes and Gallistel, |
| Per1−/− mice | Drug sensitization; cancer development | Shorter period (Zheng et al., | Normal (Feillet et al., | Unknown |
| Per2−/− mice | Drugs sensitization and alcohol consumption; cancer development | Shorter period/arrhythmic (Zheng et al., | Absent (Feillet et al., | Unknown |
| Cry1−/−/Cry2−/− mice | Without phenotypic abnormalities (van der Horst et al., | Arrhythmic under constant conditions (van der Horst et al., | Altered (Iijima et al., | Normal (Papachristos et al., |
| NPAS2−/− mice | Sleep and memory patterns | Shorter period (Dudley et al., | Delayed (Dudley et al., | Unknown |
| Bmal1−/− mice | Sleep and metabolic patterns; infertility | Arrhythmic (Bunger et al., | Absent (Mendoza, | Unknown |
| DAT−/− mice | Hyperactivity and learning impairment; insensitive to psychostimulants | Normal photoentrainment, altered amplitude in circadian body temperature (Vincent et al., | Unknown | Complete loss of temporal control (Meck et al., |
| DAT+/− mice | Insensitive to psychostimulants | Unknown | Unknown | Reduced sensitivity to clock-speed effects of MAP |
| Knockdown DAT−/− mice | Hyperactivity; impaired response habituation in novel environments | Unknown | Unknown | Overestimation of duration (Balci et al., |
| D2R transgenic mice | Impairment in tasks that require working memory and behavioral flexibility | Unknown | Unknown | Impairment in timing accuracy and precision (Drew et al., |
| Vipr2−/− mice | No differences from wild-type littermates | Arrhythmic (Sheward et al., | Normal (Sheward et al., | Unknown |
| NET−/− mice | Reduced spontaneous locomotor activity; supersensitive to psychostimulants | Unknown | Unknown | Normal (Drew et al., |
| Orexin−/− mice | Abnormal sleep homeostasis | Normal entrainment of activity and temperature to a restricted feeding schedule (Kaur et al., | Reduced (Kaur et al., | Unknown |
| PROT−/− mice | Normal motor ability; impairment in spatial memory (Meck, | Unknown | Unknown | Impairment in timing accuracy and precision (Meck, |
| GRPR−/− mice | Enhanced fear conditioning (Shumyatsky et al., | Unknown | Unknown | Normal (Balci et al., |
aFAA, food-anticipatory activity.
bVipr2, gene encoding the VIP (vasoactive intestinal peptide) receptor VPAC2.
cPROT, proline transporter.
dGRPR, gastrin-releasing peptide receptor.
eMAP, methamphetamine.
Figure 2Relationships of different neurons in the striatum and neurotransmitter signaling involved in interval timing. (A) Schematic representation of the relationship among oscillatory cortical inputs, medium spiny neurons, cholinergic interneurons, glutamatergic afferents, and dopaminergic axons projecting from the substantia nigra pars compacta (SNpc) to the striatum as specified by the Striatal Beat Frequency model of interval timing. The direct output pathway to the globus pallidus – external (GPe) and internal (GPi) segments, and substantia nigra reticulata (SNr) as well as the indirect pathway to the GPe are indicated. Relevant neurotransmitters = acetylcholine (ACh), dopamine (DA), γ-aminobutyric acid (GABA), glutamate (GLU). (B) Detail of dopaminergic, glutamatergic, and cholinergic input to a striatonigral medium spiny neuron as well as the principal signal transduction pathways modulating the contribution of striatal spiny neurons to interval timing. Abbreviations: AC, adenyl cyclase; ACh, acetylcholine; AMPAR, AMPA receptor; CB1, cannabinoid receptor type 1; CRE, cyclic-AMP-response element; CREB, CRE binding protein; DA, dopamine; DAG, 1,2-diacylglycerol; DARPP-32, camp-regulated phosphoprotein of 32 kDa; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; EC, endocannabinoids; GABA, γ-aminobutyric acid; Glu, glutamate; GP, globus pallidus; IP3, inositol 1,4,5 trisphosphate; M1R, muscrinic acetylcholine receptor 1; M2R, muscarinic acetylcholine receptor 2; mGluR, metabotropic glutamate receptor; NMDAR, N-methyl-d-aspartic acid receptor; NOS, nitric oxide synthase; PKA, protein kinase A; PKC, protein kinase C; SNpc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; STN, subthalamic nucleus; TrKR, tyrosine kinase receptor.